Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study - Top-Institutions - MDSpire

Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study

By
Shungo Yamamoto
Akihiro Shiroshita
Yuki Kataoka
Hidehiro Someko
March 5, 2025
0 min

Open Forum Infectious Diseases

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

#1

Johns Hopkins University

Baltimore, MD
Key Differentiators
- Infectious Diseases
- Pulmonology
- Epidemiology
#2

Massachusetts General Hospital / Harvard Medical School

Boston, MA
Key Differentiators
- Infectious Diseases
- Pulmonology
- Geriatrics
#3

University of California, San Francisco (UCSF)

San Francisco, CA
Key Differentiators
- Infectious Diseases
- Pulmonology
- Clinical Epidemiology
#4

University of Tokyo

Tokyo, Tokyo Prefecture
Key Differentiators
- Infectious Diseases
- Pulmonology
- Clinical Research
#5

Mayo Clinic

Rochester, MN
Key Differentiators
- Infectious Diseases
- Pulmonology
- Geriatrics

Original Source(s)

Open Forum Infectious Diseases

Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study

by Shungo Yamamoto, Akihiro Shiroshita, Yuki Kataoka, Hidehiro Someko
March 5, 2025

Related Content

Jama Network Open

Impact of Peer Feedback on Antibiotic Prescribing Practices Among Hospitalists

Stat News

Match Day results show impact of federal immigration policy

by Jonathan Wosen
March 23, 2026

Open Forum Infectious Diseases

Comparison of Periodic In-person ID Care to Daily Tele-ID Care at a Community Hospital